‘Breaking’ patents would harm innovation: think tank

The Information Technology and Innovation Foundation (ITIF) think tank has called on the US National Institutions of Health (NIH) to maintain IP protection amid calls to “break” patents in order to lower drug prices.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank

23 June 2021 Making sense of the newest Section 337 developments will be a key focus of The American Conference Institute’s 13th Annual Practitioners’ Think Tank on ITC Litigation and Enforcement.

Big Pharma

US patent reforms could re-establish gene patent eligibility, industry experts warn

6 June 2019 A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.

Americas

Gilead claims US government PrEP patents are invalid

20 May 2019 Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.

More on this story

Biotechnology

Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank

Big Pharma

US patent reforms could re-establish gene patent eligibility, industry experts warn

6 June 2019 A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.

Americas

Gilead claims US government PrEP patents are invalid

20 May 2019 Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.

More on this story

Biotechnology

Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank

Big Pharma

US patent reforms could re-establish gene patent eligibility, industry experts warn

6 June 2019 A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.

Americas

Gilead claims US government PrEP patents are invalid

20 May 2019 Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.